Dr. Brian Fife, PhD, is a research grant recipient from Regenerative Medicine Minnesota. The primary goals of this project are to restore immune homeostasis that allows islet beta cell survival and regeneration as a cure for Type 1 diabetes (T1D). We have generated novel tetramer reagents and will use them to track and phenotype diabetes relevant T cells in T1D patients. These reagents will also be coupled to toxins and used to selectively kill self-reactive T cells and allow pancreatic islet beta cells to survive and regenerate.
